We strive to improve the patient’s quality of life

OUR Mission

We at CanPharma are committed to providing patients with optimal medical care. We make sure that patients in need have access to a great variety of pharmaceuticals. To achieve that, we are not only supplying pharmacies throughout Germany with high- quality medical cannabis, we focus, together with our international network of Research & Development partners, on the full investigation of the plant and its benefits.
We also own a cultivation license in Portugal, to ensure that strains are grown, which adhere to our high requirements on the treatment. Furthermore, our goal is to educate patients, doctors and pharmacies on how to use medical cannabis in the most professional way.

OUR Expertise

Our profound expertise is reflected by our entire team of physicians, researchers and pharmaceutical experts. With our founding partners of the Kalapa Group, we have years of experience in treatments with medical cannabis and the required know-how for its professional use. CanPharma is licensed as a pharmaceutical wholesale company according to §52a of the German Medicines Act, as well as a licensed narcotic drug dealer within the meaning of §3 of the German narcotics legislation. Moreover, our quality assurance system is GDP-certified.


A core team that drives growth and success


CEO CanPharma

Dr. Henrik Sprengel

COO CanPharma

Stefan Jacker

Quality Manager

Dr. Hans Jacker

Marketing Director

Clemens Jacker

Regulatory Affairs

Holger Kilz

Business Development

Tim Meiboom

Office Management

Ulrike Rüter

Legal Counsel

Kurt Sprengel

Key Account Management

Julia Lengfeld

Key Account Management

Sergej Rausch

Medical Affairs

Stephanie Jindra

IberCanPharma Lda


Francisco Barbosa


Alexandre Barbosa

Head Grower

Shlomo Booklin

Project Manager

Alexandre Vieira

Head Pharmacist

Inês Milheiro Nunes Martins

Medical Director

Pedro Miguel De Assis Lopes Tavares da Mata

Global Group Kalapa

Managing Director

Oscar Riera

Director Web & Online

Claudia Vidrio

Sales Director MyCBD

Susana Rosell

Director Laboratory

Antonio Sanchez Espinosa

Medical Director

Dr. Mariano Garcia de Palau


Dr. David Campos


Dr. Mery Peña

Country Manager Spain

Francesca Ferreres

Country Manager Italy

Mario Romano

Country Manager France

Elizabeth Bohling

Country Manager France

Pauline Sicsik

Country Manager UK

Claire Albarico

Country Manager Germany

Dominik Kleiner

Content Manager

Alica Ücdemir

Medical Advisory Board

Medical Advisor

Dr. Mariano García de Palau

Medical Advisor

Janosch Kratz

Medical Advisor

Dr. Rüdiger Koenen

Medical Advisor

Dr. Birger Kintzel



Holger Sprengel


Melanie Wilmes


Abdullah Karadeniz


Our partners are key to fulfill our mission


We are a member of the Federal Association of the pharmaceutical industry e.V., which represents interests of the pharmaceutical industry. The association speaks for more than 260 companies with a total of more than 78,000 employees.

Storz & Bickel

Storz & Bickel belongs to the world’s leading manufacturers of vaporizers. They are the first and only manufacturer of certified medical devices for the inhalation of cannabinoids. The company has its head quarter in Tuttlingen, Germany and has been brining innovative vaporizer models to the market since 1996.


Bedrocan is one of most experienced products of medicinal cannabis in the whole world. They are producing various standardized medicinal cannabis flos (the whole, dried flower) with a constant composition of cannabinoids and terpenes. The whole production process fulfills the GMP-Guidelines (Good Manufacturing Practice).


(Association for Cannabinoids, Terpenes, and Innovative Ventures in Europe) is the first European trade association, which is linking companies, scientists, though leaders and in Investors in the field of cannabinoids and terpenes. The aim is to help to create an industry, which is safe to all users and professionals of cannabinoid-based products.


CanPharma is a Member of the The International Association for Cannabinoid Medicines. The goal of the association is to gain more knowledge on cannabis, cannabinoids, the endocannabinoid system, and other topics regarding the therapeutic potential of the plant.


The Spanish Observatory of Medicinal Cannabis (OECM) was founded in October 2015 with the need to promote, coordinate and carry out activities and projects aimed to understand the properties and the medical uses of cannabis and its derivatives.

Furthermore we are involved in various R&D Projects, to improve the scientific knowledge regarding medical cannabis.

Read More


Do you have any questions?

Logo Can Pharma SVG

CanPharma has a pharmaceutical wholesale permission according to §52a of the German Medicines Act, as well as a license to handle narcotics in the meaning of §3 of the German narcotics legislation. Furthermore, CanPharma has a GDP-certified quality assurance system.




CanPharma GmbH
Wiesbadener Str. 29
16515 Oranienburg

IberCanPharma LDA
Rua João Fernandes
Lavrador 1 – Sala 6 2825-
132 Vila Nova de Caparica


Neue Kantstraße 18
14057 Berlin

Gran de Gràcia 15, 1-1
08012 Barcelona